AI Science Tracker
EN

Learning classifies concurrent cardiac injury markers in cancer and COVID-19

Jilin Cancer Hospital · 25 Sep 2023 · medicine

Discovery

Learning classifies concurrent cardiac injury markers in cancer and COVID-19

Source check: Source checked. Not independent scientific confirmation.

Finding: A random forest combined eight laboratory and chest-imaging measures in 201 cancer patients with COVID-19. Internal evaluation distinguished patients with troponin-defined cardiac injury, with reported AUC 0.94. Predictor timing relative to injury was not established, and outcome-informed screening preceded validation. This supports an exploratory concurrent classification result, not prediction before injury or improved patient outcomes.

Technology: Random forest; LASSO feature screening

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
A random forest learns relationships between selected laboratory/imaging measurements and recorded biochemical cardiac-injury status.
Test and result
Retrospective comparison with troponin-defined injury status in 67 cases and 134 non-cases, with reported ten-fold internal validation.
Limitation / still unknown
Pre-injury forecasting, independent diagnostic validation and clinical benefit remain unestablished; imputation and outcome-informed feature ranking may introduce optimism.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11797975/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Primary relevant model Methods, Results and limitations; exact primary identity and current primary PubMed correction/retraction relationships checked..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.